Nantkwest

Developer of immunotherapy to treat cancer, infectious, and inflammatory diseases

placeCulver City, California, United States calendar_todayFounded 2002 groups641 employees language nantkwest.com

Registered entities

Innovation

53 patent families (22 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 3,356 times.

YearFilings
20152
20166
20178
201812
201917
202027
202135
202212
20239
20249
202510
20263

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon